Skip to content
CapRadio

CapRadio

signal status listen live donate
listen live donate signal status
listen live donate signal status
  • News
    • beats
    • State Government
    • Environment
    • Health Care
    • Business
    • Arts and Lifestyle
    • Food and Sustainability
    • PolitiFact California
    • California Dream
    • Videos
    • Photos
  • Music
    • genres
    • Classical
    • Jazz
    • Roots
    • Eclectic
    • Videos
    • Daily Playlist
  • Programs + Podcasts
    • news
    • Morning Edition
    • All Things Considered
    • Marketplace
    • Insight
    • The View From Here
    • music
    • Acid Jazz
    • At the Opera
    • Classical Music
    • Connections
    • Excellence in Jazz
    • Hey, Listen!
    • Insight Music
    • K-ZAP on CapRadio
    • Mick Martin's Blues Party
    • Programs A-Z
    • Podcast Directory
  • Schedules
    • News
    • Music
    • ClassicalStream
    • JazzStream
    • Weekly Schedule
    • Daily Playlist
  • Community
    • Events Calendar
    • CapRadio Garden
    • CapRadio Reads
    • CapRadio Travels
    • Ticket Giveaways
  • Support
    • Evergreen Gift
    • One-Time Gift
    • Corporate Support / Underwriting
    • Vehicle Donation
    • Stock Gift
    • Legacy Gift
    • Endowment Gift
    • Volunteering
    • Benefits
    • Member FAQ
    • e‑Newsletter
    • Drawing Winners
    • Thank You Gifts
  • About Us
  • Contact Us
  • Close Menu
 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 
  • Health Care
  • State Government
  •  

Drug Pricing Bill Faces Crucial Committee Vote

  •  Sammy Caiola 
Thursday, August 31, 2017 | Sacramento, CA
Listen
/
Update RequiredTo play audio, update browser or Flash plugin.
gregfriese / Flickr
 

gregfriese / Flickr

An ongoing drug pricing battle between Democratic Senator Ed Hernandez and the pharmaceutical industry comes to a head Friday in the California Legislature.

Hernandez’s new measure, SB17, aims to create greater transparency between drug manufacturers, health plans and consumers. He introduced a similar bill last year, but it was hijacked in the Assembly Appropriations Committee. This week, it goes to a vote in that same committee.

The new bill has support from the California Labor Federation and consumer group Health Access California. It’s opposed by Pharmaceutical Research and Manufacturers of America

Hernandez says his measure, along with other drug pricing bills up for debate this season,will ultimately lead to lower prices for consumers.

“It brings attention to an industry that traditionally has never been questioned,” he says. “But if you think about the rising prescription drug costs… I think not only my bill, but what’s happening nationwide, there is a lot of attention to the pharmaceutical drug industry, because they are making huge profits at the expense of the customer and the taxpayers.”

Drug manufacturers say the bill is too narrowly focused on one slice of the problem. Priscilla VanderVeer is a spokesperson for Pharmaceutical Research and Manufacturers of America, a trade group representing biopharmaceutical research companies.

She says the bill only looks at one level of the supply chain - the manufacturers. It also tackles the original list prices for the drugs, versus what the consumer actually pays after insurance plans and pharmacy benefit managers negotiate a price.

“It’s a very complex system, and I think this bill is trying to simplify it in a way that is not realistic,” she says.

Consumer uproar over drug pricing has been fueled by skyrocketing prices of the EpiPen, for allergies, and Sovaldi for Hepatitis. 


Follow us for more stories like this

CapRadio provides a trusted source of news because of you.  As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.

Donate Today  

 epipenEd Hernandezdrug pricingdrug costsdrug transparencySovaldiHepatitisPhRMApharmaceuticalspharmaceutical industry

Sammy Caiola

Healthcare Reporter

Sammy Caiola has been covering medical breakthroughs, fitness fads and health policy in California since 2014. Before joining CapRadio, Sammy was a health reporter at The Sacramento Bee.  Read Full Bio 

 @sammycaiola Email Sammy Caiola

Coronavirus Newsletter

Get answers to your questions, the latest updates and easy access to the resources you need, delivered to your inbox.

 

Want to know what to expect? Here's a recent newsletter.

Thanks for subscribing!

We'll send you weekly emails so you can stay informed about the coronavirus in California.

Browse all newsletters

More Health Care Stories

Gabriella Angotti-Jones for NPR

'The Separate and Unequal Health System' Highlighted By COVID-19

January 21, 2021

Anne Wernikoff / CalMatters

‘Tedious, Stressful’: Why Older Californians Are Still Struggling To Get Vaccine

January 23, 2021

Andrew Nixon / CapRadio

Sacramento County Is Expanding Vaccinations At Cal Expo, But Not Yet For The General Public

January 21, 2021

Most Viewed

California Coronavirus Updates: California Lawmakers Scramble To Extend State Eviction Moratorium

California Coronavirus Updates: State Launches Pilot Vaccine Sign-up Website

High-Speed Rail In California Moves Along, But Slowly

California Coronavirus Updates: State Sen. Nielsen Criticizes State Vaccine Rollout For Small, Rural Counties

California Attorney General Files Nine Lawsuits In One Day As Trump Leaves Office

We Get Support From:
Become a Supporter

Most Viewed

California Coronavirus Updates: California Lawmakers Scramble To Extend State Eviction Moratorium

California Coronavirus Updates: State Launches Pilot Vaccine Sign-up Website

High-Speed Rail In California Moves Along, But Slowly

California Coronavirus Updates: State Sen. Nielsen Criticizes State Vaccine Rollout For Small, Rural Counties

California Attorney General Files Nine Lawsuits In One Day As Trump Leaves Office

Back to Top

  • CapRadio

    7055 Folsom Boulevard
    Sacramento, CA 95826-2625

    • (916) 278-8900
    • Toll-free (877) 480-5900
    • Email Us
    • Submit a News Tip
  • Contact Us

  • About Us

    • Contact Us / Feedback
    • Coverage
    • Directions
    • Jobs & Internships
    • Mission / Vision / Core Values
    • Press
    • Staff Directory
    • Board of Directors
  • Listening Options

    • Mobile App
    • On Air Schedules
    • Smart Speakers
    • Playlist
    • Podcasts
    • RSS
  • Connect With Us

    •  Facebook
    •  Twitter
    •  Instagram
    •  YouTube
  • Donate

  • Listen

  • Newsletters

CapRadio stations are licensed to California State University, Sacramento. © 2021, Capital Public Radio. All Rights Reserved. Privacy Policy | Website Feedback FCC Public Files: KXJZ KKTO KUOP KQNC KXPR KXSR KXJS. For assistance accessing our public files, please call 916-278-8900 or email us.